Chiesi Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for CHIESI, and what generic alternatives to CHIESI drugs are available?
CHIESI has twelve approved drugs.
There are twenty-five US patents protecting CHIESI drugs.
There are two hundred and twenty-one patent family members on CHIESI drugs in fifty countries and sixteen supplementary protection certificates in nine countries.
Summary for Chiesi
International Patents: | 221 |
US Patents: | 25 |
Tradenames: | 13 |
Ingredients: | 7 |
NDAs: | 12 |
Patent Litigation for Chiesi: | See patent lawsuits for Chiesi |
Drugs and US Patents for Chiesi
Expired US Patents for Chiesi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | CLEVIPREX | clevidipine | EMULSION;INTRAVENOUS | 022156-002 | Aug 1, 2008 | 5,739,152 | See Plans and Pricing |
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-003 | Feb 21, 1992 | 3,985,758 | See Plans and Pricing |
Chiesi | KENGREAL | cangrelor | POWDER;INTRAVENOUS | 204958-001 | Jun 22, 2015 | 6,114,313 | See Plans and Pricing |
Chiesi | CLEVIPREX | clevidipine | EMULSION;INTRAVENOUS | 022156-003 | Nov 8, 2013 | 5,856,346 | See Plans and Pricing |
Chiesi | ZYFLO CR | zileuton | TABLET, EXTENDED RELEASE;ORAL | 022052-001 | May 30, 2007 | 5,422,123 | See Plans and Pricing |
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-001 | Feb 21, 1992 | 3,985,758 | See Plans and Pricing |
Chiesi | CLEVIPREX | clevidipine | EMULSION;INTRAVENOUS | 022156-001 | Aug 1, 2008 | 5,856,346 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHIESI drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 2.5 mg/mL, 10 mL Ampoules | ➤ Subscribe | 2006-12-27 |
➤ Subscribe | Inhalation Solution | 300 mg/4 mL | ➤ Subscribe | 2017-08-31 |
➤ Subscribe | Injection | 0.1 mg/mL, 200 mL and0.2mg/mL, 200 mL | ➤ Subscribe | 2013-06-20 |
➤ Subscribe | Tablets | 500 mg | ➤ Subscribe | 2016-01-29 |
International Patents for Chiesi Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 3077514 | See Plans and Pricing |
Hong Kong | 1068784 | See Plans and Pricing |
Japan | 2009534409 | See Plans and Pricing |
Mexico | 2020004107 | See Plans and Pricing |
China | 1864696 | See Plans and Pricing |
Eurasian Patent Organization | 006068 | See Plans and Pricing |
Japan | 2001509512 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chiesi Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0726894 | SPC/GB12/011 | United Kingdom | See Plans and Pricing | PRODUCT NAME: CLEVIDIPINE; REGISTERED: UK PL16881/0003 20111123 |
0726894 | C300520 | Netherlands | See Plans and Pricing | PRODUCT NAME: CLEVIDIPINE; NAT. REGISTRATION NO/DATE: RVG 104771 20111129; FIRST REGISTRATION: PL 16881/0003 20111123 |
0748228 | 11C0002 | France | See Plans and Pricing | PRODUCT NAME: MANNITOL; NAT. REGISTRATION NO/DATE: NL 34557 20080819; FIRST REGISTRATION: SE - 22708 20061020 |
0726894 | 92209 | Luxembourg | See Plans and Pricing | PRODUCT NAME: CLEVIDIPINE SOUS TOUTES LES FORMES PROCURANT UNE PROTECTION A PARTIR DU BREVET DE BASE |
1280520 | CA 2015 00017 | Denmark | See Plans and Pricing | PRODUCT NAME: TOBRAMYCIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/10/652/001-003 20110720 |
0726894 | 12C0053 | France | See Plans and Pricing | PRODUCT NAME: CLEVIDIPINE; NAT. REGISTRATION NO/DATE: NL 37621 20120725; FIRST REGISTRATION: GB - PL 16881/0003 20111123 |
1280520 | C01280520/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.